Strata Skin Sciences Inc (SSKN)
0.3936
+0.01
(+3.14%)
USD |
NASDAQ |
May 17, 16:00
0.3955
0.00 (0.00%)
After-Hours: 20:00
Strata Skin Sciences Net Income (Quarterly): -3.794M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.794M |
| September 30, 2023 | -1.053M |
| June 30, 2023 | -3.148M |
| March 31, 2023 | -2.835M |
| December 31, 2022 | -0.16M |
| September 30, 2022 | -0.995M |
| June 30, 2022 | -1.892M |
| March 31, 2022 | -2.502M |
| December 31, 2021 | -0.849M |
| September 30, 2021 | -0.521M |
| June 30, 2021 | 1.082M |
| March 31, 2021 | -2.418M |
| December 31, 2020 | -0.443M |
| September 30, 2020 | -1.254M |
| June 30, 2020 | -1.68M |
| March 31, 2020 | -1.035M |
| December 31, 2019 | -0.515M |
| September 30, 2019 | -0.86M |
| June 30, 2019 | -1.082M |
| March 31, 2019 | -1.333M |
| December 31, 2018 | 0.285M |
| September 30, 2018 | -0.608M |
| June 30, 2018 | -1.629M |
| March 31, 2018 | -2.081M |
| December 31, 2017 | -4.403M |
| Date | Value |
|---|---|
| September 30, 2017 | -13.67M |
| June 30, 2017 | -1.205M |
| March 31, 2017 | -2.235M |
| December 31, 2016 | -0.887M |
| September 30, 2016 | -1.509M |
| June 30, 2016 | 0.498M |
| March 31, 2016 | -1.437M |
| December 31, 2015 | -0.593M |
| September 30, 2015 | -9.234M |
| June 30, 2015 | -7.847M |
| March 31, 2015 | -7.272M |
| December 31, 2014 | -4.504M |
| September 30, 2014 | -2.288M |
| June 30, 2014 | 0.627M |
| March 31, 2014 | -7.981M |
| December 31, 2013 | -4.610M |
| September 30, 2013 | -7.404M |
| June 30, 2013 | -7.422M |
| March 31, 2013 | -6.512M |
| December 31, 2012 | -6.079M |
| September 30, 2012 | -5.357M |
| June 30, 2012 | -5.484M |
| March 31, 2012 | -5.753M |
| December 31, 2011 | -4.522M |
| September 30, 2011 | -6.111M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-3.794M
Minimum
Dec 2023
1.082M
Maximum
Jun 2021
-1.366M
Average
-1.053M
Median
Sep 2023
Net Income (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -12.28M |
| Retractable Technologies Inc | -0.0729M |
| Xtant Medical Holdings Inc | -4.40M |
| Asensus Surgical Inc | -22.50M |
| Catheter Precision Inc | -2.675M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 8.689M |
| Total Expenses (Quarterly) | 9.846M |
| EPS Diluted (Quarterly) | -0.11 |
| Enterprise Value | 22.06M |
| Gross Profit Margin (Quarterly) | 55.25% |
| Profit Margin (Quarterly) | -43.66% |
| Earnings Yield | -78.76% |
| Normalized Earnings Yield | -55.57 |